Defence Therapeutics Inc. Net Asset Momentum
Defence Therapeutics Inc. net asset momentum. Defence Therapeutics Inc. (DTC) recorded a net asset momentum of -328.9% as of June 2024, with net assets of €-3.58 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check cash flow reinvestment rate of Defence Therapeutics Inc. to assess the company's total reinvestment commitment from operating cash flow.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Defence Therapeutics Inc. (2020–2024)
Net asset momentum of Defence Therapeutics Inc. from 2020 to 2024. This chart tracks Defence Therapeutics Inc.'s year-over-year net asset growth across 5 annual reporting periods from 2020 to 2024. The most recent momentum reading is -328.9%, with net assets of €-3.58 Million EUR as of June 2024. See what is Defence Therapeutics Inc.'s book value for net asset value and shareholders' equity analysis.
Defence Therapeutics Inc. Net Asset Momentum by Year (2020–2024)
Defence Therapeutics Inc. net asset momentum by year from 2020 to 2024. The table below shows the complete annual net asset history for Defence Therapeutics Inc. from 2020 to 2024, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market value of Defence Therapeutics Inc..
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | €-3.58 Million | €477.75K | €4.06 Million | ▼ -328.9% |
| 2023 | €1.57 Million | €3.53 Million | €1.97 Million | ▲ +504.1% |
| 2022 | €-387.56K | €719.67K | €1.11 Million | ▼ -107.1% |
| 2021 | €5.49 Million | €5.61 Million | €122.26K | ▲ +194.4% |
| 2020 | €1.86 Million | €1.91 Million | €48.35K | — |